Physician profile
Madison Werber
NPI 1528624772
$1,728.56
in general payments reported to CMS, 2019-2025
16 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,067 · 2022: $56.54 · 2023: $108 · 2024: $238 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $579.99 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $132.77 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.33 | 2021 | |
| Phathom Pharmaceuticals, INC. | $124.45 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.65 | 2021 | |
| Janssen Biotech, INC. | $110.91 | 2021 | |
| Mallinckrodt Hospital Products INC. | $107.75 | 2023 | Terlivaz |
| Astrazeneca Pharmaceuticals Lp | $107.62 | 2021 | |
| Aesculap Implant Systems, LLC | $105.00 | 2021 | |
| Qol Medical, LLC | $85.78 | 2021 | |
| Celgene Corporation | $34.87 | 2021 | |
| Ironwood Pharmaceuticals, INC | $28.37 | 2021 | |
| Gilead Sciences, INC. | $24.83 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.91 | 2021 | |
| Redhill Biopharma INC. | $12.90 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Werber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.